chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On December 23rd, around 5:30-6:00 p.m. I received the Moderna COVID-19 Vaccine EUA  at the Vaccination Site.  I did not have any adverse symptoms until the night of December 24th around 11:30 p.m.  It started that night with nausea.  I initially thought it was something I had eaten. I went to bed feeling nauseous but fell asleep.  I slept through the night, and work up the next morning, December 25th,  still nauseous.  I did not ever vomit, even though I very much thought I would.   As the day progressed, I developed chills and a low-grade fever.  This continued through the day. The nausea was terrible! I could not eat anything because the mere thought of food made me feel sicker. I drank very little as well.  I also developed flu like symptoms.  I could not stand to be touched, as my skin was highly sensitive to touch.  (The same feeling you get if you have a bad case of the flu.)  I used a cold wet washcloth all day, as I felt hot, but my fever never went over 99.7 degrees.  I eventually fell asleep that night, but I was restless. I woke up several times to noises in my home. Each time it felt like my body was trembling or my heart was racing or fluttering, but these episodes did not last long, nor could I tell you for sure that was exactly what it was. I just felt shaky.  Each time I fell back asleep.  The next morning, December 26th, I awoke, and the nausea was gone, but the chills and the fever were still hanging on.  I just felt bad!  I used a cold wet washcloth on my forehead, face, and neck all day.  I did eat maybe 5-10 dry saltine crackers and drank a glass or two of sprite.  As the day progressed, I felt worse!!  The nausea came and went all afternoon and into the night. I eventually fell asleep around 10-11:00 p.m.  I slept all night. I awoke the next morning, December 27th, initially feeling nauseous again.  I made it a point to drink a lot of Gatorade and sprite throughout the day.  I found that I felt some better when I sat up but felt worse when I laid down. So, I sat for about an hour on the side of my bed. I eventually got up and walked around my house. I began to feel better and thought I might be able to shower and possibly eat. So, I did? and it was like my body did a 180!  I quickly felt so much better. I ate some soup and drank some sprite. I didn?t completely go back to my normal routine, but I did stay up the remainder of the day and did not get sick. The next day, December 28th, I felt like myself again and pretty much went back to my normal routine.   The most interesting side effects that I had that are not mentioned in the CDC COVID-19 Vaccine common side effects are: *My feet were ice cold, but they were wet with sweat (I put on socks to try to warm them up, but it did not help as my socks would get damp thus making my feet colder) *My tongue became coated white  (I did not lose my sense of taste or smell) *My skin felt hot to me, even though it was not hot to the touch (I used a cold wet washcloth for 2-3 days straight)
I was fine throughout the day, when I went to bed I was fine. Woke up about 1am, noting a high fever and violently flailing around the bed uncontrollably, unable to control body movements. Woke up around 5am, relieved that it felt like my temp had broken. I took my temp with a thermometer and it was 102, which meant to me that at 1am my fever was likely 103 - 104 and the flailing around was probably a seizure brought on by a very high fever.  At about 5 am I took a tylenol, slept awhile, fever didn't come back and I felt much better by that afternoon.
Systemic: Shakiness-Severe, Systemic: Tachycardia-Severe, Additional Details: uncontrolable shaking. patient stated that benadryl has helped her in the past with this type of reaction. gave benadryl. patient has a history of having reactions to vaccines. 911 was called and brought her to the hospital.
Initial information received on 31-Jul-2018 regarding an unsolicited valid non-serious case received from other health care professional. This case involves a 20 years old patient (gender unknown) who received 0.5ml dose of suspect MENACTRA, lot U5567CA, expiry date 28 Jun 2018 via intramuscular route in the left deltoid on 31-Jul-2018. The patients past medical history and family history were not provided. The patient did not receive any concomitant medication. It was an actual medication error due to expired vaccine used. It was reported that patient received MENACTRA on 31 Jul 2018 which expired on 28 Jun 2018. Patient has not experienced any adverse reactions after the injection.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender- none.
Given 1/11/08, Tdap.  Sore and fatigue that night.  1/12/08 fever, fatigue.  1/13/08 chills, malaise, nausea, "wooziness".  Still with problems today.  Difficulty sleeping.  Right arm swollen and tender.
Received vaccine 10/18/11 at 1800. Arm at injection site red, swollen & warm to touch in a.m. on 10/19/11. Redness increased & patient saw primary care physician on 10/21/11.
Tonsillitis, fatigue, sore tongue, gas, foot pain, pain on left side of head.
While I?ve been report on the vsafe that I?ve often on had extreme exhaustion, starting last night 2/12/21, I started feeling pain in the injection site as bad as I did the first few days. It?s extremely red and feels like there?s a nodule beneath the skin. It?s hurts to move that arm.
dizziness; fatigue; nausea; chills; warm to the touch at the injection site; injection site arm was sore/ Injection site arm was tender; Injection site arm was red; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), VACCINATION SITE WARMTH (warm to the touch at the injection site), VACCINATION SITE PAIN (injection site arm was sore/ Injection site arm was tender), VACCINATION SITE ERYTHEMA (Injection site arm was red) and FATIGUE (fatigue) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch at the injection site), VACCINATION SITE PAIN (injection site arm was sore/ Injection site arm was tender) and VACCINATION SITE ERYTHEMA (Injection site arm was red). On 01-May-2021, the patient experienced DIZZINESS (dizziness), FATIGUE (fatigue), NAUSEA (nausea) and CHILLS (chills). On 21-Apr-2021, VACCINATION SITE WARMTH (warm to the touch at the injection site) and VACCINATION SITE ERYTHEMA (Injection site arm was red) had resolved, VACCINATION SITE PAIN (injection site arm was sore/ Injection site arm was tender) outcome was unknown. At the time of the report, DIZZINESS (dizziness), FATIGUE (fatigue), NAUSEA (nausea) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MODERNATX, INC.-MOD-2021-114449 (E2B Linked Report).; Sender's Comments: MODERNATX, INC.-MOD-2021-114449:crosslinked; husband case
stomach cramping; patient received a dose of recombivax HB after its labelled expiration date; This spontaneous report was received from medical assistant (also an office manager) regarding a 21-year-old Adult female patient. Patient's pertinent medical history, drug allergies/reactions, concurrent conditions and concomitant therapies were not reported.  On 17-APR-2019, the patient was vaccinated with hepatitis b vaccine (recombinant) (RECOMBIVAX HB) 10/1.0 mcrg/ml (microgram/milliliter) (strength) (lot # M039201, expiry date: November 2018) via intramuscular route for prophylaxis. Patient received hepatitis b vaccine (recombinant) (RECOMBIVAX HB) after its labelled expiration date (expired product administered). On 27-APR-2019, the patient experienced some stomach cramping (abdominal pain upper). The patient did not seek for any medical attention nor received any treatment. The outcome of abdominal pain upper was reported as resolved in April 2019. No product quality complaint was involved. Causality assessment was not provided by the reporter.
CHILLS; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced chills, and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fatigue. This report was non-serious.
A nurse reported the occurrence of "feeling blah" in an adult male of unspecified age who was vaccinated with Hep B vaccine recombinant (Engerix-B). Medical history included an allergy to penicillin and hypertension. Concurrent medications included an unspecified medication for high blood pressure. On 10/8/02 the subject received his first injection of Engerix-B. Approximately two days later, on 10/10/02 the subject reported "feeling blah". The subject informed the reporter that he did not have a fever, chills or inject site reaction, he just was not feeling well. As of 10/11/02 the outcome of the event was unknown.
Patient didn't receive the 2nd dose of vaccine after 42 days of receiving 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient didn't receive the 2nd dose of vaccine after 42 days of receiving 1st dose) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient didn't receive the 2nd dose of vaccine after 42 days of receiving 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient didn't receive the 2nd dose of vaccine after 42 days of receiving 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment drugs details was reported.
pt fussy during noc-up w/pt several times on & off;last check 03:30 went in @ 05:30 or 06:00 @ foot of crib pt found cool & mottled;EMT tried to resuscitate w/no results & again in ER;
Nausea, vomiting, diarrhea (explosive and extensive over a period of ~10 hours)
Received vaccine #2 04/08/2021.  Fell at home 04/09/2021 and was transferred to ER and they admitted her to hospital for Urinary Sepsos.
brilliant scarlet chevron 1 inch in size under injection site; evolved to 5cm x 12cm pink lesion.  patient also developed anxiety and foggy feeling.  pateint did seek medical attention.  patient was prescribed hydroxyzine 10mg tablet for swelling and anxiety.  md said not to get next dose
Generalized tonic clonic seizure lasting less than 5 min. No measured fever during or after the event. This happened once the afternoon of the day after his immunization. He was taken by ambulance to the emergency room after the event at 1428 on 4/13
PATIENT RECEIVED VACCINE 15 DAYS EARLY (ACCORDING TO 28 DAY SCHEDULE). WAS INFORMED THAT SECOND DOSE IS 28 DAYS AFTER AND WAS MENTIONED AT TIME OF VACCINE THAT PT MARKED LAST VACCINE WITHIN 14 DAYS BUT DUE TO MISCOMMUNICATION AND OTHER PATIENTS MISTAKING IT FOR THEIR LAST COVID VACCINE WITHIN 28 DAYS THEREFORE SHOT WAS MISTAKENLY GIVEN EARLY.
body ache; weakness; dizziness; This case was reported by a physician via sales rep and described the occurrence of general body pain in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included hyperthyroidism and palpitation.   On 28th October 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced general body pain, weakness and dizziness. On an unknown date, the outcome of the general body pain, weakness and dizziness were recovered/resolved.   It was unknown if the reporter considered the general body pain, weakness and dizziness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, after vaccination with 1st dose of shingrix, the patient had severe body ache, dizziness and weakness which disappeared after 2 days. The patient stated that, could not determine if Shingrix was the reason for adverse events following vaccination. The patient would likely to return for second dose
Patient is suspected to have received 0.3mL of undiluted vaccine (150mcg vs 30mcg).  Patient reported having a dull headache 3/10 pain scale since yesterday afternoon post vaccination.  Patient also reported soreness in her right arm down to her elbow.   She did not experience any other symptoms.
Fever, chronic cough, fatigue, trouble breathing, runny nose, stuffy nose, sore throat, . Went to the Dr was reported  I had a respiratory infection.
Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Dizziness / Lightheadness-Mild, Additional Details: 2 shots were administered..moderna bivalent and flucelvax, pt started to fell dizzy and started to have skin rash, emt were contacted immediately, Emt advised not to give any food,drinks or medications, emt arrived checked vitals and vitals were ok per emt, paretns were given option to for the pt to go to hospital by ambulance or with them, parents decided to go on their on their own.
Patient sat down. Syringe was injected in to left arm. Vaccine squirted out because needle probably wasn't clamped well on syringe. Moderna vaccine was injected the first time. A second shot was given with no issues. Patient is fine with no immediate side effects. Patient was educated about possible side effects of the vaccine and introduced to agency . observed for 20 minutes. Recorded by Client.
Sudden onset of nausea, abdominal pain and sweats. Chills and diarrhea. Most symptoms subsided after a 1-2 hours, but lower abdominal pain and feeling of having a bowel movement continued.
VACCINE ADMINISTERED AFTER BEING STORED IN FREEZER; VACCINE PLACED IN FREEZER UPON RECEIPT ABOUT 1 WEEK LATER; This spontaneous report received from a health care professional concerned a 4 decade old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811, and expiry: 20-MAR-2022) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient experienced vaccine administered after being stored in freezer, and vaccine placed in freezer upon receipt about 1 week later. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine administered after being stored in freezer and vaccine placed in freezer upon receipt about 1 week later was not reported. This report was non-serious. This case, from the same reporter is linked to 20220146230.
I had a flu-like symptom--sore stomach, nausea and then the rash started.
achy feeling in his arm; This case was reported by a nurse via call center representative and described the occurrence of pain in arm in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix in left arm and he experienced an achy feeling in his arm which has resolved.   The reporter consented to follow up. The GlaxoSmithKline could follow up with the reporter directly. For tolerances of 2nd dose, refer case US2020AMR107530, reported by same reporter for the same patient. This case linked with US2020107109, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020107109:same reporter US-GLAXOSMITHKLINE-US2020AMR107530:same reporter
He was fine until exactly 7 days post-injection when he grabbed his upper left arm and said "ow it hurts".  He had a large, round  red swelling greater than 3 mm in diameter,  It felt hot to the touch.  After it did not resolve within two days, I took him to be seen by his primary doctor's practice.  They said they thought it was an injection reaction and to treat it with ice packs and ibuprofen, which we did for a couple of days.  It improved significantly that weekend.  Now, three weeks later, there is only mild discoloration remaining at the injection site.
Fever, nausea, vomiting, diarrhea, spitting up foam, sweating, chills for a duration of two weeks
ZOSTAVAX administer, injection site reaction 1-2 in diameter swelling and redness with pain radiating up and down her upper arm. Pt states swelling and redness continued to expand.
The patient is a healthy 44-year-old female who noted localized pain after receipt of influenza vaccine IIV (manufacturer SmithKline lot # 7AJ5J) to her left deltoid. She reports she noted no initial or immediate pain. She reports she noted mild local pain at the injection area the next day. She states she didn't particularly pay attention that approximately 2 weeks later she noted worsening shoulder pain at the subacromion was initially severe enough she left work. She states the pain is continued. It affects ADLs such as dressing. She notes it mostly with extension especially above shoulder level. The pain is currently 2/10. She has been taking ibuprofen or NAPROSYN one to times a day. She did try a topical diclofenac patch which was not effective. She continues her routine exercise program which is ballet dance approximately 5 days per week. She states she likely would not have noted it is related to vaccine receipt except the injection was very high in the deltoid. She has no weakness or restricted ROM. She denies prior injury to her shoulder. She reports she took ibuprofen, likely 400 mg, prior to vaccine receipt to mitigate adverse effects and routinely following the vaccine. She denies immediate reaction after vaccine receipt consistent with IgE allergy including no urticaria, dyspnea, oral facial throat swelling. She denies systemic reaction of fever chills malaise, cough, headache, arthralgias or myalgias. She denies local site reaction of erythema edema, warmth or induration.
2-3 red bumps with "heads".  Sore throat and swollen tongue.  No treatment.
A week after getting my 1st Vaccine in my left arm, my left hand began to have pain and numbness.  My ring finger and middle finder were sore and tender and my left thumb and index finger had numbness.  It was to the point it was waking me up at night.  When I went in for my 2nd dose I told the nurse.  She said to go to my family doctor.  I got my 2nd shot in right arm by the way.  Pfizer 03/14/2021 Lot#EN6204.   I did a tele visit 1st via work clinic and they said to go in to be checked by family doctor.  I went in right away.  They did a blood test to check for any inflammation.  Called me back and said none - normal.  They referred me to a hand orthopedic.  In the mean time my right hand became swollen about a week after the 2nd dose (no numbness).  Dr did an x-ray and found no fractures.  He suspected it may be carpel tunnel in my left hand and "Vikings Disease" (Dupuytren's contracture) in my right hand as there is a small nodule center of my palm that developed that  did not have previously.   He said to take 2 Aleve 2 times a day for 3 weeks to see if that reduced the pain.   He had me go to a neurologist to get tested for carpel tunnel. Tests came back positive for carpel tunnel in left hand.  I am right handed by the way.  Went back to orthopedic Dr for next steps.  He recommended a cortisone shot and a treatment of  oral steroids for several days (less each day I took them until gone).   They helped by still had numbness in thumb.  Dr said to come back for follow-up and then recommended surgery for carpel tunnel release which I just hand on 7/29/2021.
Itching, 3 plaques of dermatitis on upper arm where influenza vaccine given, but not directly over site of immunization.
Pain in injected left arm at shoulder/Pain in right arm at shoulder; Pain in muscle in arm of injection/Pain in right shoulder muscle; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain in injected left arm at shoulder/Pain in right arm at shoulder) and MYALGIA (Pain in muscle in arm of injection/Pain in right shoulder muscle) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS, Acid reflux (oesophageal), Hyperlipidemia and Depression.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced ARTHRALGIA (Pain in injected left arm at shoulder/Pain in right arm at shoulder) and MYALGIA (Pain in muscle in arm of injection/Pain in right shoulder muscle). At the time of the report, ARTHRALGIA (Pain in injected left arm at shoulder/Pain in right arm at shoulder) and MYALGIA (Pain in muscle in arm of injection/Pain in right shoulder muscle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications included thyroid medication, acid reflux medication, antihyperlipidemic medication and antidepressant medication (not specified). The patient did not take any treatment medication..   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24-MAY-2021: Contain Non significant follow up
The vaccine given had a expiration of 3/18/2022. A stability report requested from Moderna came back fine; showing full activity against COVID-19. The patient reported no adverse events with the booster.
Temperature 103.3, joint pain left arm pain, pain in neck, back, neck swelling took Ibuprofen/TYLENOL. Symptoms greater than 24 hours
Swelling in upper left arm and armpit 48 hours after administration of Menveo and Tdap in that location. Patient is able to use arm but is painful. The patient is afebrile. There is a 1 inch tender left axillary lymph node with two pea sized mobile nodes adjacent.